Loading...
XKRX145720
Market cap368mUSD
Dec 24, Last price  
62,300.00KRW
1D
0.97%
1Q
-22.90%
IPO
75.49%
Name

Dentium Co Ltd

Chart & Performance

D1W1MN
XKRX:145720 chart
P/E
5.57
P/S
1.37
EPS
11,192.69
Div Yield, %
0.48%
Shrs. gr., 5y
—
Rev. gr., 5y
16.11%
Revenues
393.19b
+10.49%
70,758,942,75061,976,635,65073,921,730,87087,142,224,11095,489,314,480120,033,552,220150,645,643,720186,316,233,650252,587,272,920229,749,431,320291,529,687,470355,865,975,040393,188,581,130
Net income
96.52b
+12.15%
14,136,136,0007,410,915,89014,769,359,12016,140,928,86014,481,024,33019,793,092,31030,066,434,81034,253,295,53014,785,641,22022,544,714,00055,484,056,50086,066,136,12096,524,197,067
CFO
64.99b
+38.24%
2,346,839,48014,380,771,07013,625,454,8206,162,926,17014,971,325,50017,601,158,70021,659,104,760-574,593,400-11,642,097,63075,754,918,14074,111,673,80047,011,431,13064,988,760,000
Dividend
Dec 27, 2023400 KRW/sh
Earnings
Feb 26, 2025

Profile

Dentium Co.,Ltd. manufactures and sells dental implant products worldwide. Its dental implant systems include superline, implantium, simpleline II, slimline, overdenture system, NR line, and implantium II. The company also provides surgical instruments, such as surgical, drill stopper, sinus, osteotome, trephine bur, prosthetic, planning, restorative, and help kits, as well as harvest drills, sinus elevators, GBR systems, surgical guides, temporary shells, white seals, TN brushes, and guide systems; regeneration products, including bone grafts, membranes, and tissue regeneration products; and digital dentistry products. In addition, it offers lab products; and iCT motors and injections. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. The company was founded in 2000 and is headquartered in Seoul, South Korea.
URL
https://www.dentium.co.kr/dsn/
IPO date
Mar 15, 2017
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
393,188,581
10.49%
355,865,975
22.07%
291,529,687
26.89%
Cost of revenue
185,791,058
157,777,021
162,059,435
Unusual Expense (Income)
NOPBT
207,397,523
198,088,954
129,470,252
NOPBT Margin
52.75%
55.66%
44.41%
Operating Taxes
37,954,241
32,250,961
19,218,302
Tax Rate
18.30%
16.28%
14.84%
NOPAT
169,443,282
165,837,993
110,251,950
Net income
96,524,197
12.15%
86,066,136
55.12%
55,484,056
146.11%
Dividends
(2,587,167)
(2,155,973)
(1,724,778)
Dividend yield
0.23%
0.25%
0.29%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
163,633,126
138,269,316
96,992,702
Long-term debt
51,205,265
77,487,858
97,954,553
Deferred revenue
Other long-term liabilities
1,816,882
1,848,301
2,901,817
Net debt
127,926,605
107,025,355
95,346,106
Cash flow
Cash from operating activities
64,988,760
47,011,431
74,111,674
CAPEX
(44,146,509)
(54,111,178)
(29,042,555)
Cash from investing activities
(47,196,776)
(49,029,968)
(21,778,284)
Cash from financing activities
(2,791,589)
8,769,203
(24,059,520)
FCF
69,390,801
81,738,507
112,953,685
Balance
Cash
86,911,786
72,053,558
65,841,353
Long term investments
36,678,261
33,759,797
Excess cash
67,252,357
90,938,521
85,024,665
Stockholders' equity
432,477,583
343,849,065
261,568,154
Invested Capital
607,193,316
475,818,647
386,197,857
ROIC
31.29%
38.48%
27.48%
ROCE
30.75%
34.95%
27.48%
EV
Common stock shares outstanding
8,624
8,624
8,624
Price
131,000.00
31.00%
100,000.00
43.27%
69,800.00
69.83%
Market cap
1,129,729,721
31.00%
862,389,100
43.27%
601,947,592
68.71%
EV
1,256,926,872
968,697,268
696,552,107
EBITDA
228,281,687
217,037,499
142,675,895
EV/EBITDA
5.51
4.46
4.88
Interest
7,433,383
6,792,914
6,077,153
Interest/NOPBT
3.58%
3.43%
4.69%